Kristen D Starbuck MD

PubMed

• Induction chemotherapy with cemiplimab in a patient with coexistent vulvar cancer and autoimmune disease: A case report.
  Elizabeth G Thayer, M Larissa Weirich, Zoe A Roecker, Sara E Brenner, Jill S Remick
  Gynecologic Oncology Reports. 2024-10-01
• Case report: intravenous leiomyomatosis with intracaval and intracardiac growth.
  Daniel S Kikuchi, Clive A Goulbourne, Kristen D Starbuck, Marcelo F Fernandes
  European Heart Journal. Case Reports. 2023-01-01
• 3 citations
  Incidence and predictors of toxicity in the management of vulvar squamous cell carcinoma treated with radiation therapy.
  Neal S McCall, Tony Y Eng, Joseph W Shelton, Sheela Hanasoge, Pretesh R Patel
  Gynecologic Oncology Reports. 2022-12-01

Journal Articles

• Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature  
  Starbuck KD, Drake RD, Budd GT, Rose PG, Anticancer Res, 1/1/2016
• Patterns of Care, Predictors and Outcomes of Chemotherapy for Uterine Carcinosarcoma: A population-based analysis  
  Rauh-Hain JA, Starbuck KD, Clemmer J, Schorge JO, Lu KH, del Carmen MG, Gynecol Oncol, 1/1/2015
• Multimodal therapy in the treatment of vaginal adenocarcinoma arising in endocervicosis  
  Starbuck K, Garcia C, Wu Q, Runowicz CD, Gynecol Oncol, 1/1/2011
• Genome-wide comparison of paired fresh frozen and formalin-fixed paraffin-embedded gliomas by custom BAC and oligonucleotide array comparative genomic hybridization: f...  
  Mohapatra G, Engler DA, Starbuck KD, Kim JC, Bernay DC, Scangas GA, Rousseau A, Batchelor TT, Betensky RA, Louis DN, Acta Neuropathol, 1/1/2011
• Join now to see all

Books/Book Chapters

• Immune Checkpoint Inhibitors in Cancer 
  Chapter: Immune Checkpoint Inhibitors in Cancer 
  Kristen Starbuck, MD; Paul Mayor, MD MS; Emese Zsiros, MD, PhDElsevier, 1st2018

Abstracts/Posters

• Starbuck KD, Bshara W, Eng KH, Morrell K, Lele S, Frederick P, Akers S, Zsiros E, Odunsi K, SGO, 1/1/2018
• Variability in body mass index during adjuvant chemotherapy is associated with clinical outcomes among patients with ovarian cancer undergoing adjuvant chemotherapy
  Starbuck KD, Cannioto R, Etter JL, Duncan W, Morrell K, Almohanna H, Joseph JM, Szender JB, Odunsi K, Lele S, Frederick P, Akers S, Eng KH, Zsiros E, Moysich KB, SGO, 1/1/2018
• Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer
  Starbuck KD, Szender JB, Morrell K, Etter JH, Odunsi K, Eng KH, Zsiros E, SGO, 1/1/2018
• CXCR4 in combination with immune checkpoint inhibition in ovarian cancer mouse model demonstrates potential for novel therapeutic strategies
  K. Starbuck, R. McGray, S. Masoumi-Moghaddam, A. Francois, K. Odunsi, E. Zsiros, AACR, 1/1/2017
• Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model
  Starbuck, R. McGray, S. Masoumi-Moghaddam, A. Francois, K. Odunsi, E. Zsiros, AACR, 1/1/2017
• Targeting a chemoresistant ovarian cancer cell population via the carbohydrate antigen Sialyl Tn
  B Rueda, K Starbuck, D Eavarone, J Prendergast, J Stein, R Foster, J Behrens, Ovarian Cancer Research Symposium, Seattle, WA, 1/1/2016
• Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen Sialyl-Tn
  Starbuck K, Eavarone D, Prendergast J, da Silva APG, DeSander J, Behrens J, Rueda B, Foster R, Dana Farber/Harvard Cancer Center Breast and Gynecologic Cancer Symposium, 1/1/2016
• Eradicating ovarian cancer stem cells by targeting the tumor-associated carbohydrate antigen sialyl Tn
  K. Starbuck, D. Eavarone, J. Prendergast, A.P.G. da Silva, J. DeSander, J. Behrens, B. Rueda, R. Foster, NEAGO, 1/1/2015
• Patterns of Care, Predictors and Outcomes of Chemotherapy for Uterine Carcinosarcoma: A population-based analysis
  K. Starbuck, J. Alejandro Rauh-Hain, Joel Clemmer, John O. Schorge, Marcela G. del Carmen, NEAGO, 1/1/2015
• The Role of Sialyl-Tn in Ovarian Cancer
  K. Starbuck, MGH Gynecologic Oncology Faculty, 1/1/2015
• Cost comparison of robotic, single port and conventional laparoscopy for early stage endometrial cancer
  Knight, K Starbuck, P Escobar, 43rd SGO, 1/1/2012
• Join now to see all